Baxdrostat and finerenone: new aldosterone synthase-aldosterone-mineralocorticoid receptor hormonal system inhibitors for the drug treatment of resistant arterial hypertension

• 主要な著者: O. B. Kuzmin (著者), N. V. Buchneva (著者), V. V. Belyanin (著者), V. V. Zhezha (著者), M. V. Stolbova (著者)
• フォーマット: 図書
• 出版事項: Столичная издательская компания, 2024-10-01T00:00:00Z.
• 主題: article
• オンライン･アクセス: Connect to this object online.

Resistant arterial hypertension is characterized by failure to control target blood pressure despite long-term use of optimal or maximum tolerated doses of three different antihypertensive drugs, including diuretic. Patients with resistant hypertension are included in a group of people at high risk...